We are live on ! Find out more

206 hedge funds and large institutions have $3.58B invested in Insmed in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 60 increasing their positions, 83 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $6.65M | Put options by funds: $3.35M

33% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 24

3% more funds holding

Funds holding: 200206 (+6)

2% more capital invested

Capital invested by funds: $3.5B → $3.58B (+$83.6M)

1.63% less ownership

Funds ownership: 107.24%105.61% (-1.6%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

28% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 83

Holders
206
Holders Change
+6
Holders Change %
+3%
% of All Funds
3.65%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
32
Increased
60
Reduced
83
Closed
24
Calls
$6.65M
Puts
$3.35M
Net Calls
+$3.29M
Net Calls Change
-$1.87M
Name Holding Trade Value Shares
Change
Change in
Stake
CWC
226
Carolinas Wealth Consulting
North Carolina
-$2K -47 Closed
Group One Trading
227
Group One Trading
Illinois
-$1.31K -36 Closed
GLLW
228
Graves Light Lenhart Wealth
Virginia
+$73 +2 New

INSM Hedge Fund Activity: Q4 2020 in Review

206 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2020, worth a combined $3.58B — up 2.4% from $3.5B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new INSM positions and 24 closed out — a net gain of 8 holders — while 60 added to existing stakes and 83 trimmed.

The largest buyer was William Blair Investment Management, adding an estimated $48.1M. The largest seller was Fidelity Investments, cutting an estimated $114M.

  • 206 institutional investors held Insmed (INSM) as of Q4 2020, up from 200 in Q3 2020.
  • Funds reported $3.58B of Insmed stock for Q4 2020, up 2.4% quarter-over-quarter.
  • 32 funds opened new Insmed positions in Q4 2020 and 24 closed out, a net change of +8 holders.
  • The largest Insmed buyer in Q4 2020 was William Blair Investment Management, an estimated $48.1M added.
  • The largest Insmed seller in Q4 2020 was Fidelity Investments, an estimated $114M sold.

Based on aggregated 13F filings for Q4 2020.